A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma

Figure 1

CCP acts as the most significant risk factor of HCC prognosis in TCGA-LIHC cohort. (a) Multivariate cox regression models that included glycolysis, CCP, age, gender, grade, and stage. (b) Heat map showing the associations between CCP score and clinicopathological parameters. (c) Prognostic analysis of HCC patients with high and low CCP score.

(a)

(b)

(c)